INanoBio’s mission is to develop high-accuracy early stage disease diagnostics using transformative nano-biotechnology platforms and machine learning. Extract systems scale information from complex disease biology, identify and detect disease specific molecular biomarkers, signatures at prodromal or pre-symptomatic stages. We believe most diseases can be detected early, enabling early personalized therapeutic intervention to preempt full development of diseases, ushering in preemptive medicine.
Looking for a particular INanoBio employee's phone or email?
The INanoBio annual revenue was $1 million in 2026.
Marwan Khater is the Senior Director, Device Development of INanoBio.
3 people are employed at INanoBio.
INanoBio is based in Scottsdale, Arizona.
The NAICS codes for INanoBio are [541, 541714, 54, 5417, 54171].
The SIC codes for INanoBio are [87, 873].